The Food and Drug Administration's Federal Review of a Pediatric Muscular Dystrophy Protocol

IRB. 2018 Jan-Feb;40(1):18-20.
No abstract available

MeSH terms

  • Child
  • Drug Evaluation*
  • Ethics Committees, Research
  • Humans
  • Muscular Dystrophies* / drug therapy
  • Pharmaceutical Preparations
  • United States
  • United States Food and Drug Administration*

Substances

  • Pharmaceutical Preparations